Sanofi & Teva Pharma’s RELIEVE UCCD phase 2b study of duvakitug in ulcerative colitis and Crohn’s disease meets primary endpoints: Paris Thursday, December 19, 2024, 11:00 Hrs ...

Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping ...

Teva and Sanofi report positive Phase 2b data for duvakitug, showing significant remission in UC and CD patients, boosting ...

The dramatic rise is another peak in Teva's recovery over the past year and rewards investors after a long period of ...

We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look ...

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...

Late-stage ozanimod trials are ongoing in ulcerative colitis and Crohn’s disease. Zeposia has been approved by the FDA on the strength of the phase 3 RADIANCE and SUNBEAM trials, which showed it ...

Shutdown Grows Closer as Trump Tells G.O.P. to Kill Spending Deal The bill Republicans and Democrats agreed on is in jeopardy after President-elect Trump condemned it three days before the ...

December 18, 2024 • At a federal prison in rural Virginia, more than 50 prisoners say they've been abused. But when they try to file a complaint — they're stopped, often by the same guards ...

EXCLUSIVETrail of Google Street View clues that snared a killer: A mystery figure with a wheelbarrow, a 'body' getting stuffed in a car boot... the astonishing train of events that could solve a ...